Idenis

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Tue, 01/19/21 - 09:18 pm
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi